1. Pune mega capacity expansion - A new Pune facility (₹40 cr capex, 75% bank-funded) starts production at 25% capacity in FY27 and reaches 100% within two years, adding cosmetics, adhesives, and personal-care verticals. Management guides FY27 revenue of ₹180 cr-plus including Pune’s partial contribution, a 24% jump over FY26’s ₹146 cr, with the full ramp-up roughly doubling the company’s current installed capacity.
2. LexaMix strategic collaboration - Tipco has exclusive rights to sell LexaMix machinery in India and will manufacture for LexaMix in Europe, South America, and the Middle East. The tie-up opens a direct export channel in high-value process machinery while adding three new end-markets - cosmetics, pharma, and food processing - that diversify revenue away from the dominant paints segment.
3. Defence manufacturing - DRDO partnership - DRDO (HEMRL) has approved and is recommending Tipco for high-end defence products, including a lab-scale machine for rocket-fuel dispersion priced at \~₹36 lakh per unit. Defence orders carry long qualification cycles but, once won, tend to be sticky and high-margin, fitting management’s stated shift toward customized engineered systems.
4. Export expansion - Export share doubled to 7.1% of revenue in FY26 from 3.05% in FY25, with business added in Europe, the Gulf, and Africa. The LexaMix partnership and DRDO approvals give concrete channels to accelerate this trajectory, lifting the mix toward higher-realization international projects.
5. Import substitution - pricing power vs. European peers - Tipco prices at 6 versus European competitors’ 10 while offering technology management calls “really same,” and at 6 versus Indian peers’ 4. That pricing gap creates headroom to win share from imports in a market that still relies heavily on European engineering systems, without sacrificing the margin premium over local rivals.
6. Order book and H2 momentum - The order book stands at ₹60-70 cr, and H2 FY26 revenue grew 66% YoY to ₹95.8 cr. With smaller orders converting in 30-45 days and larger ones in 3-6 months, the near-term revenue pipeline is already substantially covered relative to the FY27 guided run-rate.
7. Margin step-up from mix shift - FY26 EBITDA margin expanded 867 bps to 26.6%, driven by customized engineered systems, export-led projects, and technology-linked applications. As Pune and LexaMix volumes layer on at higher complexity, the margin base resets well above the sub-18% levels of FY25, compounding profit growth even on moderate revenue gains.